| 1 |
Sokolova O, Naumann M. NF-κB Signaling in Gastric Cancer.Toxins (Basel). 2017;9:119. [PMID: 28350359 DOI: 10.3390/toxins9040119] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 17.8] [Reference Citation Analysis]
|
| 2 |
Deenonpoe R, Chomvarin C, Pairojkul C, Chamgramol Y, Loukas A, Brindley PJ, Sripa B. The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter. Asian Pac J Cancer Prev 2015;16:1751-8. [PMID: 25773821 DOI: 10.7314/apjcp.2015.16.5.1751] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 3 |
Kinoshita-Daitoku R, Kiga K, Miyakoshi M, Otsubo R, Ogura Y, Sanada T, Bo Z, Phuoc TV, Okano T, Iida T, Yokomori R, Kuroda E, Hirukawa S, Tanaka M, Sood A, Subsomwong P, Ashida H, Binh TT, Nguyen LT, Van KV, Ho DQD, Nakai K, Suzuki T, Yamaoka Y, Hayashi T, Mimuro H. A bacterial small RNA regulates the adaptation of Helicobacter pylori to the host environment. Nat Commun 2021;12:2085. [PMID: 33837194 DOI: 10.1038/s41467-021-22317-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 4 |
Katoh H, Ishikawa S. Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations. J Hum Genet 2021;66:887-99. [PMID: 34267306 DOI: 10.1038/s10038-021-00960-8] [Reference Citation Analysis]
|
| 5 |
Su T, Li F, Guan J, Liu L, Huang P, Wang Y, Qi X, Liu Z, Lu L, Wang D. Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling. Phytomedicine 2019;63:152968. [PMID: 31280140 DOI: 10.1016/j.phymed.2019.152968] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 6 |
de Brito BB, Lemos FFB, Carneiro CDM, Viana AS, Barreto NMPV, Assis GAS, Braga BDC, Santos MLC, Silva FAFD, Marques HS, Silva NOE, de Melo FF. Immune response to Helicobacter pylori infection and gastric cancer development. World J Meta-Anal 2021; 9(3): 257-276 [DOI: 10.13105/wjma.v9.i3.257] [Reference Citation Analysis]
|
| 7 |
Xia W, Khan I, Li XA, Huang G, Yu Z, Leong WK, Han R, Ho LT, Wendy Hsiao WL. Adaptogenic flower buds exert cancer preventive effects by enhancing the SCFA-producers, strengthening the epithelial tight junction complex and immune responses. Pharmacol Res 2020;159:104809. [PMID: 32502642 DOI: 10.1016/j.phrs.2020.104809] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 8 |
Elhariri M, Hamza D, Elhelw R, Hamza E. Occurrence of cagA+ vacA s1a m1 i1 Helicobacter pylori in farm animals in Egypt and ability to survive in experimentally contaminated UHT milk. Sci Rep 2018;8:14260. [PMID: 30250213 DOI: 10.1038/s41598-018-32671-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 9 |
Xie C, Li N, Wang H, He C, Hu Y, Peng C, Ouyang Y, Wang D, Xie Y, Chen J, Shu X, Zhu Y, Lu N. Inhibition of autophagy aggravates DNA damage response and gastric tumorigenesis via Rad51 ubiquitination in response to H. pylori infection. Gut Microbes 2020;11:1567-89. [PMID: 32588736 DOI: 10.1080/19490976.2020.1774311] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 10 |
Alexander SM, Retnakumar RJ, Chouhan D, Devi TNB, Dharmaseelan S, Devadas K, Thapa N, Tamang JP, Lamtha SC, Chattopadhyay S. Helicobacter pylori in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes. Front Microbiol 2021;12:713955. [PMID: 34484153 DOI: 10.3389/fmicb.2021.713955] [Reference Citation Analysis]
|
| 11 |
Tabata N, Sueta D, Arima Y, Okamoto K, Shono T, Hanatani S, Takashio S, Oniki K, Saruwatari J, Sakamoto K, Kaikita K, Sinning JM, Werner N, Nickenig G, Sasaki Y, Fukui T, Tsujita K. Cytotoxin-associated gene-A-seropositivity and Interleukin-1 polymorphisms influence adverse cardiovascular events. Int J Cardiol Heart Vasc 2020;27:100498. [PMID: 32181324 DOI: 10.1016/j.ijcha.2020.100498] [Reference Citation Analysis]
|
| 12 |
Xiong Y, Yang Z, Zhang J, Li J, Chen P, Xiang Y. Panning using a phage-displayed random peptide library to identify peptides that antagonize the Helicobacter pylori ArsS acid-sensing domain. Microb Pathog 2019;135:103614. [PMID: 31255726 DOI: 10.1016/j.micpath.2019.103614] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 13 |
Nishikawa H, Hatakeyama M. Sequence Polymorphism and Intrinsic Structural Disorder as Related to Pathobiological Performance of the Helicobacter pylori CagA Oncoprotein. Toxins (Basel). 2017;9. [PMID: 28406453 DOI: 10.3390/toxins9040136] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Idowu A, Mzukwa A, Harrison U, Palamides P, Haas R, Mbao M, Mamdoo R, Bolon J, Jolaiya T, Smith S, Ally R, Clarke A, Njom H. Detection of Helicobacter pylori and its virulence genes (cagA, dupA, and vacA) among patients with gastroduodenal diseases in Chris Hani Baragwanath Academic Hospital, South Africa. BMC Gastroenterol. 2019;19:73. [PMID: 31088381 DOI: 10.1186/s12876-019-0986-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 15 |
Weitzman MD, Weitzman JB. What's the damage? The impact of pathogens on pathways that maintain host genome integrity. Cell Host Microbe. 2014;15:283-294. [PMID: 24629335 DOI: 10.1016/j.chom.2014.02.010] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 16 |
Torres K, Valderrama E, Sayegh M, Ramírez JL, Chiurillo MA. Study of the oipA genetic diversity and EPIYA motif patterns in cagA-positive Helicobacter pylori strains from Venezuelan patients with chronic gastritis. Microb Pathog 2014;76:26-32. [PMID: 25223715 DOI: 10.1016/j.micpath.2014.09.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 17 |
Devi TB, Devadas K, George M, Gandhimathi A, Chouhan D, Retnakumar RJ, Alexander SM, Varghese J, Dharmaseelan S, Chandrika SK, Jissa VT, Das B, Nair GB, Chattopadhyay S. Low Bifidobacterium Abundance in the Lower Gut Microbiota Is Associated With Helicobacter pylori-Related Gastric Ulcer and Gastric Cancer. Front Microbiol 2021;12:631140. [PMID: 33717022 DOI: 10.3389/fmicb.2021.631140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 18 |
Suzuki H, Mori H. World trends for H. pylori eradication therapy and gastric cancer prevention strategy by H. pylori test-and-treat. J Gastroenterol. 2018;53:354-361. [PMID: 29138921 DOI: 10.1007/s00535-017-1407-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 19 |
Gutiérrez-González LH, Santos-Mendoza T. Viral targeting of PDZ polarity proteins in the immune system as a potential evasion mechanism. FASEB J 2019;33:10607-17. [PMID: 31336050 DOI: 10.1096/fj.201900518R] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 20 |
Saito Y, Desai RR, Muthuswamy SK. Reinterpreting polarity and cancer: The changing landscape from tumor suppression to tumor promotion. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2018;1869:103-16. [DOI: 10.1016/j.bbcan.2017.12.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 21 |
Kakiuchi T, Matsuo M, Endo H, Nakayama A, Sato K, Takamori A, Sasaki K, Takasaki M, Hara M, Sakata Y, Okuda M, Kikuchi S, Eguchi Y, Takahashi H, Anzai K, Fujimoto K. A Helicobacter pylori screening and treatment program to eliminate gastric cancer among junior high school students in Saga Prefecture: a preliminary report. J Gastroenterol 2019;54:699-707. [DOI: 10.1007/s00535-019-01559-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 22 |
Dávila-Collado R, Jarquín-Durán O, Dong LT, Espinoza JL. Epstein-Barr Virus and Helicobacter Pylori Co-Infection in Non-Malignant Gastroduodenal Disorders. Pathogens 2020;9:E104. [PMID: 32041355 DOI: 10.3390/pathogens9020104] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 23 |
Koeppel M, Garcia-alcalde F, Glowinski F, Schlaermann P, Meyer T. Helicobacter pylori Infection Causes Characteristic DNA Damage Patterns in Human Cells. Cell Reports 2015;11:1703-13. [DOI: 10.1016/j.celrep.2015.05.030] [Cited by in Crossref: 81] [Cited by in F6Publishing: 65] [Article Influence: 11.6] [Reference Citation Analysis]
|
| 24 |
Zucca E, Bertoni F. The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood 2016;127:2082-92. [DOI: 10.1182/blood-2015-12-624304] [Cited by in Crossref: 121] [Cited by in F6Publishing: 101] [Article Influence: 20.2] [Reference Citation Analysis]
|
| 25 |
Nell S, Estibariz I, Krebes J, Bunk B, Graham DY, Overmann J, Song Y, Spröer C, Yang I, Wex T, Korlach J, Malfertheiner P, Suerbaum S. Genome and Methylome Variation in Helicobacter pylori With a cag Pathogenicity Island During Early Stages of Human Infection. Gastroenterology 2018;154:612-623.e7. [DOI: 10.1053/j.gastro.2017.10.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 26 |
Yang H, Zhou X, Hu B. The "reversibility" of chronic atrophic gastritis after the eradication of Helicobacter pylori. Postgrad Med 2022. [PMID: 35382697 DOI: 10.1080/00325481.2022.2063604] [Reference Citation Analysis]
|
| 27 |
Yang S, Xia YP, Luo XY, Chen SL, Li BW, Ye ZM, Chen SC, Mao L, Jin HJ, Li YN, Hu B. Exosomal CagA derived from Helicobacter pylori-infected gastric epithelial cells induces macrophage foam cell formation and promotes atherosclerosis. J Mol Cell Cardiol. 2019;135:40-51. [PMID: 31352044 DOI: 10.1016/j.yjmcc.2019.07.011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 28 |
Loh JT, Lin AS, Beckett AC, McClain MS, Cover TL. Role of a Stem-Loop Structure in Helicobacter pylori cagA Transcript Stability. Infect Immun 2019;87:e00692-18. [PMID: 30510104 DOI: 10.1128/IAI.00692-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 29 |
Ohashi W, Hattori K, Hattori Y. Control of Macrophage Dynamics as a Potential Therapeutic Approach for Clinical Disorders Involving Chronic Inflammation. J Pharmacol Exp Ther 2015;354:240-50. [DOI: 10.1124/jpet.115.225540] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 30 |
Maldonado RF, Sá-Correia I, Valvano MA. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev 2016;40:480-93. [PMID: 27075488 DOI: 10.1093/femsre/fuw007] [Cited by in Crossref: 185] [Cited by in F6Publishing: 163] [Article Influence: 30.8] [Reference Citation Analysis]
|
| 31 |
Caston RR, Sierra JC, Foegeding NJ, Truelock MD, Campbell AM, Frick-Cheng AE, Bimczok D, Wilson KT, McClain MS, Cover TL. Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants. Infect Immun 2020;88:e00032-20. [PMID: 32284370 DOI: 10.1128/IAI.00032-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 32 |
Kontizas E, Tastsoglou S, Karamitros T, Karayiannis Y, Kollia P, Hatzigeorgiou AG, Sgouras DN. Impact of Helicobacter pylori Infection and Its Major Virulence Factor CagA on DNA Damage Repair. Microorganisms 2020;8:E2007. [PMID: 33339161 DOI: 10.3390/microorganisms8122007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 33 |
Zaika AI, Wei J, Noto JM, Peek RM. Microbial Regulation of p53 Tumor Suppressor. PLoS Pathog 2015;11:e1005099. [PMID: 26379246 DOI: 10.1371/journal.ppat.1005099] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 34 |
Zhao Y, Gao X, Guo J, Yu D, Xiao Y, Wang H, Li Y. Helicobacter pylori infection alters gastric and tongue coating microbial communities. Helicobacter. 2019;24:e12567. [PMID: 30734438 DOI: 10.1111/hel.12567] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
|
| 35 |
Steinestel K, Wardelmann E, Hartmann W, Grünewald I. Regulators of Actin Dynamics in Gastrointestinal Tract Tumors. Gastroenterol Res Pract 2015;2015:930157. [PMID: 26345720 DOI: 10.1155/2015/930157] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 36 |
Li JC, Chen QH, Jian R, Zhou JR, Xu Y, Lu F, Li JQ, Zhang H. The Partial Role of KLF4 and KLF5 in Gastrointestinal Tumors. Gastroenterol Res Pract 2021;2021:2425356. [PMID: 34367275 DOI: 10.1155/2021/2425356] [Reference Citation Analysis]
|
| 37 |
Roy RK, Hoppe MM, Srivastava S, Samanta A, Sharma N, Tan KT, Yang H, Voon DC, Pang B, Teh M, Murata-Kamiya N, Hatakeyama M, Chang YT, Yong WP, Ito Y, Ho KY, Tan P, Soong R, Koeffler PH, Yeoh KG, Jeyasekharan AD. CEACAM6 is upregulated by Helicobacter pylori CagA and is a biomarker for early gastric cancer. Oncotarget 2016;7:55290-301. [PMID: 27421133 DOI: 10.18632/oncotarget.10528] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 38 |
Kao CY, Sheu BS, Wu JJ. Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis. Biomed J. 2016;39:14-23. [PMID: 27105595 DOI: 10.1016/j.bj.2015.06.002] [Cited by in Crossref: 152] [Cited by in F6Publishing: 133] [Article Influence: 25.3] [Reference Citation Analysis]
|
| 39 |
Chaiyadet S, Sotillo J, Smout M, Cantacessi C, Jones MK, Johnson MS, Turnbull L, Whitchurch CB, Potriquet J, Laohaviroj M, Mulvenna J, Brindley PJ, Bethony JM, Laha T, Sripa B, Loukas A. Carcinogenic Liver Fluke Secretes Extracellular Vesicles That Promote Cholangiocytes to Adopt a Tumorigenic Phenotype. J Infect Dis 2015;212:1636-45. [PMID: 25985904 DOI: 10.1093/infdis/jiv291] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 12.9] [Reference Citation Analysis]
|
| 40 |
Pakharukova MY, Zaparina O, Hong SJ, Sripa B, Mordvinov VA. A comparative study of Helicobacter pylori infection in hamsters experimentally infected with liver flukes Opisthorchis felineus, Opisthorchis viverrini, or Clonorchis sinensis. Sci Rep 2021;11:7789. [PMID: 33833389 DOI: 10.1038/s41598-021-87446-x] [Reference Citation Analysis]
|
| 41 |
Caston RR, Loh JT, Voss BJ, McDonald WH, Scholz MB, McClain MS, Cover TL. Effect of environmental salt concentration on the Helicobacter pylori exoproteome. J Proteomics 2019;202:103374. [PMID: 31063819 DOI: 10.1016/j.jprot.2019.05.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 42 |
Tag Eldeen LA, Mohamed MA, Awad MM, Sheir MI, Shams TM, Ragheb MM. A variety of Helicobacter pylori strains colonize the stomach of non-bleeding Egyptian patients with upper gastrointestinal disorders. Bull Natl Res Cent 2019;43. [DOI: 10.1186/s42269-019-0224-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 43 |
Yasunaga JI, Matsuoka M. Oncogenic spiral by infectious pathogens: Cooperation of multiple factors in cancer development. Cancer Sci 2018;109:24-32. [PMID: 29143406 DOI: 10.1111/cas.13443] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 44 |
Wang J, Liu Y, Sun W, Zhang Q, Gu T, Li G. Plasma exosomes as novel biomarker for the early diagnosis of gastric cancer. Cancer Biomark 2018;21:805-12. [PMID: 29400660 DOI: 10.3233/CBM-170738] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 45 |
Jafarzadeh A, Larussa T, Nemati M, Jalapour S. T cell subsets play an important role in the determination of the clinical outcome of Helicobacter pylori infection. Microb Pathog 2018;116:227-36. [PMID: 29407232 DOI: 10.1016/j.micpath.2018.01.040] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 46 |
Yuan L, Zhao JB, Zhou YL, Qi YB, Guo QY, Zhang HH, Khan MN, Lan L, Jia CH, Zhang YR, Ding SZ. Type I and type II Helicobacter pylori infection status and their impact on gastrin and pepsinogen level in a gastric cancer prevalent area. World J Gastroenterol 2020; 26(25): 3673-3685 [PMID: 32742135 DOI: 10.3748/wjg.v26.i25.3673] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Magalhaes A, Marcos-Pinto R, Nairn AV, dela Rosa M, Ferreira RM, Junqueira-Neto S, Freitas D, Gomes J, Oliveira P, Santos MR. Helicobacter pylori chronic infection and mucosal inflammation switches the human gastric glycosylation pathways. Biochimica Et Biophys Acta-Molecular Basis Dis. 2015;1852:1928-1939. [PMID: 26144047 DOI: 10.1016/j.bbadis.2015.07.001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 48 |
de Klerk N, Maudsdotter L, Gebreegziabher H, Saroj SD, Eriksson B, Eriksson OS, Roos S, Lindén S, Sjölinder H, Jonsson AB. Lactobacilli Reduce Helicobacter pylori Attachment to Host Gastric Epithelial Cells by Inhibiting Adhesion Gene Expression. Infect Immun 2016;84:1526-35. [PMID: 26930708 DOI: 10.1128/IAI.00163-16] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 49 |
Ansari S, Yamaoka Y. Helicobacter pylori Virulence Factor Cytotoxin-Associated Gene A (CagA)-Mediated Gastric Pathogenicity. Int J Mol Sci. 2020;21. [PMID: 33050101 DOI: 10.3390/ijms21197430] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 50 |
Ninomiya R, Kubo S, Baba T, Kajiwara T, Tokunaga A, Nabeka H, Doihara T, Shimokawa T, Matsuda S, Murakami K, Aigaki T, Yamaoka Y, Hamada F. Inhibition of low-density lipoprotein uptake by Helicobacter pylori virulence factor CagA. Biochem Biophys Res Commun 2021;556:192-8. [PMID: 33845309 DOI: 10.1016/j.bbrc.2021.03.170] [Reference Citation Analysis]
|
| 51 |
Servin AL. Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges. Clin Microbiol Rev 2014;27:823-69. [PMID: 25278576 DOI: 10.1128/CMR.00036-14] [Cited by in Crossref: 40] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 52 |
Toyoshima O, Nishizawa T, Sakitani K, Yamakawa T, Watanabe H, Yoshida S, Nakai Y, Hata K, Ebinuma H, Suzuki H, Koike K. Nodularity-like appearance in the cardia: novel endoscopic findings for Helicobacter pylori infection. Endosc Int Open. 2020;8:E770-E774. [PMID: 32490162 DOI: 10.1055/a-1136-9890] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 53 |
Gao S, Song D, Liu Y, Yan H, Chen X. Helicobacter pylori CagA Protein Attenuates 5-Fu Sensitivity of Gastric Cancer Cells Through Upregulating Cellular Glucose Metabolism. Onco Targets Ther 2020;13:6339-49. [PMID: 32753880 DOI: 10.2147/OTT.S230875] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 54 |
Loh JT, Gaddy JA, Algood HM, Gaudieri S, Mallal S, Cover TL. Helicobacter pylori adaptation in vivo in response to a high-salt diet. Infect Immun 2015;83:4871-83. [PMID: 26438795 DOI: 10.1128/IAI.00918-15] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 55 |
Zhou C, Jiang M, Ye X, Liu X, Zhao W, Ma L, Zhou C. Antibacterial Activities of Peptide HF-18 Against Helicobacter pylori and its Virulence Protein CagA. Int J Pept Res Ther 2022;28. [DOI: 10.1007/s10989-022-10372-7] [Reference Citation Analysis]
|
| 56 |
Suzuki H, Mori H. Different Pathophysiology of Gastritis between East and West? An Asian Perspective. Inflamm Intest Dis 2016;1:123-8. [PMID: 29922667 DOI: 10.1159/000446301] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 57 |
Guo Y, Xu C, Gong R, Hu T, Zhang X, Xie X, Chi J, Li H, Xia X, Liu X. Exosomal CagA from Helicobacter pylori aggravates intestinal epithelium barrier dysfunction in chronic colitis by facilitating Claudin-2 expression. Gut Pathog 2022;14:13. [PMID: 35331316 DOI: 10.1186/s13099-022-00486-0] [Reference Citation Analysis]
|
| 58 |
Safikhani Mahmoodzadeh A, Moazamian E, Shamsedin SA, Kaydani GA. Prevalence of Virulence Genes and Antigen Pattern in Helicobacter pylori-Infected Patients and The Level of Some Inflammatory Cytokines Compared with Non-infected Individuals. Jundishapur J Microbiol 2022;15. [DOI: 10.5812/jjm-121144] [Reference Citation Analysis]
|
| 59 |
Nishikawa H, Hayashi T, Arisaka F, Senda T, Hatakeyama M. Impact of structural polymorphism for the Helicobacter pylori CagA oncoprotein on binding to polarity-regulating kinase PAR1b. Sci Rep 2016;6:30031. [PMID: 27445265 DOI: 10.1038/srep30031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 60 |
Shimoda A, Ueda K, Nishiumi S, Murata-Kamiya N, Mukai SA, Sawada S, Azuma T, Hatakeyama M, Akiyoshi K. Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA. Sci Rep. 2016;6:18346. [PMID: 26739388 DOI: 10.10.38/srep18346] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 61 |
Yao X, Smolka AJ. Gastric Parietal Cell Physiology and Helicobacter pylori-Induced Disease. Gastroenterology 2019;156:2158-73. [PMID: 30831083 DOI: 10.1053/j.gastro.2019.02.036] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
|
| 62 |
Klymiuk I, Bilgilier C, Stadlmann A, Thannesberger J, Kastner MT, Högenauer C, Püspök A, Biowski-Frotz S, Schrutka-Kölbl C, Thallinger GG, Steininger C. The Human Gastric Microbiome Is Predicated upon Infection with Helicobacter pylori. Front Microbiol 2017;8:2508. [PMID: 29312210 DOI: 10.3389/fmicb.2017.02508] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 10.2] [Reference Citation Analysis]
|
| 63 |
Seib K, Jennings M. Epigenetics of Infectious Diseases. Medical Epigenetics. Elsevier; 2016. pp. 443-58. [DOI: 10.1016/b978-0-12-803239-8.00024-7] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 64 |
Beckett AC, Loh JT, Chopra A, Leary S, Lin AS, McDonnell WJ, Dixon BREA, Noto JM, Israel DA, Peek RM Jr, Mallal S, Algood HMS, Cover TL. Helicobacter pylori genetic diversification in the Mongolian gerbil model. PeerJ 2018;6:e4803. [PMID: 29796347 DOI: 10.7717/peerj.4803] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 65 |
Liu Y, Wang S, Yang F, Chi W, Ding L, Liu T, Zhu F, Ji D, Zhou J, Fang Y, Zhang J, Xiang P, Zhang Y, Zhao H. Antimicrobial resistance patterns and genetic elements associated with the antibiotic resistance of Helicobacter pylori strains from Shanghai. Gut Pathog 2022;14:14. [PMID: 35354484 DOI: 10.1186/s13099-022-00488-y] [Reference Citation Analysis]
|
| 66 |
Kartika AV, Iizasa H, Ding D, Kanehiro Y, Tajima Y, Kaji S, Yanai H, Yoshiyama H. Application of Biopsy Samples Used for Helicobacter pylori Urease Test to Predict Epstein-Barr Virus-Associated Cancer. Microorganisms 2020;8:E923. [PMID: 32570907 DOI: 10.3390/microorganisms8060923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 67 |
Echizen K, Hirose O, Maeda Y, Oshima M. Inflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathways. Cancer Sci. 2016;107:391-397. [PMID: 27079437 DOI: 10.1111/cas.12901] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 17.3] [Reference Citation Analysis]
|
| 68 |
Yang H, Wei B, Hu B. Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer. Inflamm Res 2021;70:1015-26. [PMID: 34549319 DOI: 10.1007/s00011-021-01501-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 69 |
Senda M, Hayashi T, Hatakeyama M, Takeuchi K, Sasaki AT, Senda T. Use of Multiple Cryoprotectants to Improve Diffraction Quality from Protein Crystals. Crystal Growth & Design 2016;16:1565-71. [DOI: 10.1021/acs.cgd.5b01692] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 70 |
Salavati S, Ahmadi Hedayati M, Ahmadi A, Fakhari S, Jalili A. Relationship between Helicobacter pylori cagA Genotypes Infection and IL-10 and TGFβ1 Genes' Expression in Gastric Epithelial Cells. Int J Prev Med 2020;11:20. [PMID: 32175060 DOI: 10.4103/ijpvm.IJPVM_536_18] [Reference Citation Analysis]
|
| 71 |
Toracchio S, Caruso RA, Perconti S, Rigoli L, Betri E, Neri M, Verginelli F, Mariani-Costantini R. Evolutionarily-Related Helicobacter pylori Genotypes and Gastric Intraepithelial Neoplasia in a High-Risk Area of Northern Italy. Microorganisms 2020;8:E324. [PMID: 32110918 DOI: 10.3390/microorganisms8030324] [Reference Citation Analysis]
|
| 72 |
Ghosh P. The stress polarity pathway: AMPK 'GIV'-es protection against metabolic insults. Aging (Albany NY) 2017;9:303-14. [PMID: 28209925 DOI: 10.18632/aging.101179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 73 |
Gonzalez-Rivera C, Bhatty M, Christie PJ. Mechanism and Function of Type IV Secretion During Infection of the Human Host. Microbiol Spectr 2016;4. [PMID: 27337453 DOI: 10.1128/microbiolspec.VMBF-0024-2015] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 74 |
Hatakeyama M. A Sour Relationship between BabA and Lewis b. Cell Host Microbe 2017;21:318-20. [PMID: 28279343 DOI: 10.1016/j.chom.2017.02.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 75 |
Keilberg D, Ottemann KM. How Helicobacter pylori senses, targets and interacts with the gastric epithelium: H. pylori -gastric epithelium interaction. Environ Microbiol 2016;18:791-806. [DOI: 10.1111/1462-2920.13222] [Cited by in Crossref: 44] [Cited by in F6Publishing: 40] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 76 |
Willet SG, Mills JC. Stomach Organ and Cell Lineage Differentiation: from Embryogenesis to Adult Homeostasis. Cell Mol Gastroenterol Hepatol 2016;2:546-59. [PMID: 27642625 DOI: 10.1016/j.jcmgh.2016.05.006] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 77 |
Zhou S, Yao D, Guo L, Teng L. Curcumin suppresses gastric cancer by inhibiting gastrin-mediated acid secretion. FEBS Open Bio 2017;7:1078-84. [PMID: 28781948 DOI: 10.1002/2211-5463.12237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 78 |
Zeyaullah M, AlShahrani AM, Ahmad I. Association of Helicobacter pylori Infection and Host Cytokine Gene Polymorphism with Gastric Cancer. Can J Gastroenterol Hepatol 2021;2021:8810620. [PMID: 34136433 DOI: 10.1155/2021/8810620] [Reference Citation Analysis]
|
| 79 |
Mwangi C, Njoroge S, Tshibangu-Kabamba E, Moloo Z, Rajula A, Devani S, Matsumoto T, Nyerere K, Kariuki S, Revathi G, Yamaoka Y. Whole Genome Sequencing Reveals Virulence Potentials of Helicobacter pylori Strain KE21 Isolated from a Kenyan Patient with Gastric Signet Ring Cell Carcinoma. Toxins (Basel) 2020;12:E556. [PMID: 32872465 DOI: 10.3390/toxins12090556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 80 |
Sokolova O, Naumann M. Crosstalk Between DNA Damage and Inflammation in the Multiple Steps of Gastric Carcinogenesis. Curr Top Microbiol Immunol 2019;421:107-37. [PMID: 31123887 DOI: 10.1007/978-3-030-15138-6_5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 81 |
Imai S, Ooki T, Murata-Kamiya N, Komura D, Tahmina K, Wu W, Takahashi-Kanemitsu A, Knight CT, Kunita A, Suzuki N, Del Valle AA, Tsuboi M, Hata M, Hayakawa Y, Ohnishi N, Ueda K, Fukayama M, Ushiku T, Ishikawa S, Hatakeyama M. Helicobacter pylori CagA elicits BRCAness to induce genome instability that may underlie bacterial gastric carcinogenesis. Cell Host Microbe 2021;29:941-958.e10. [PMID: 33989515 DOI: 10.1016/j.chom.2021.04.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 82 |
Ansari S, Yamaoka Y. Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity. Toxins (Basel). 2019;11. [PMID: 31752394 DOI: 10.3390/toxins11110677] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 83 |
Kinoshita H, Hayakawa Y, Koike K. Metaplasia in the Stomach-Precursor of Gastric Cancer? Int J Mol Sci. 2017;18:pii: E2063. [PMID: 28953255 DOI: 10.3390/ijms18102063] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 84 |
Nakano M, Hirayama T. Response to 'Helicobacter pylori infection of AZ-521 cells reveals a type IV secretion defect and VacA-independent CagA phosphorylation'. Dis Model Mech 2017;10:1541-3. [PMID: 29259028 DOI: 10.1242/dmm.032821] [Reference Citation Analysis]
|
| 85 |
Li N, Feng Y, Hu Y, He C, Xie C, Ouyang Y, Artim SC, Huang D, Zhu Y, Luo Z, Ge Z, Lu N. Helicobacter pylori CagA promotes epithelial mesenchymal transition in gastric carcinogenesis via triggering oncogenic YAP pathway. J Exp Clin Cancer Res 2018;37:280. [PMID: 30466467 DOI: 10.1186/s13046-018-0962-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 86 |
Najar MA, Modi PK, Ramesh P, Sidransky D, Gowda H, Prasad TSK, Chatterjee A. Molecular Profiling Associated with Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 (CAMKK2)-Mediated Carcinogenesis in Gastric Cancer. J Proteome Res 2021;20:2687-703. [PMID: 33844560 DOI: 10.1021/acs.jproteome.1c00008] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 87 |
Sukhan DS, Vernygorodskyi SV, Haidukov NV, Ludkevich HP. Molecular and Genetic Aspects of Helicobacter pylori Interaction with Cells of Gastric Mucosa. Cytol Genet 2020;54:147-53. [DOI: 10.3103/s0095452720020139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 88 |
Yang T, Wang R, Zhang J, Bao C, Zhang J, Li R, Chen X, Wu S, Wen J, Wei S, Li H, Cai H, Yang X, Zhao Y. Mechanism of berberine in treating Helicobacter pylori induced chronic atrophic gastritis through IRF8-IFN-γ signaling axis suppressing. Life Sci 2020;248:117456. [PMID: 32097666 DOI: 10.1016/j.lfs.2020.117456] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 89 |
Farrell P. Pathogenesis: Infections causing gastric cancer. Nat Microbiol 2016;1. [DOI: 10.1038/nmicrobiol.2016.38] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 90 |
Gurung SK, Dana S, Mandal K, Mukhopadhyay P, Mondal N. Downregulation of c-Myc and p21 expression and induction of S phase arrest by naphthalene diimide derivative in gastric adenocarcinoma cells. Chem Biol Interact 2019;304:106-23. [PMID: 30840857 DOI: 10.1016/j.cbi.2019.02.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 91 |
Boccellato F, Woelffling S, Imai-Matsushima A, Sanchez G, Goosmann C, Schmid M, Berger H, Morey P, Denecke C, Ordemann J, Meyer TF. Polarised epithelial monolayers of the gastric mucosa reveal insights into mucosal homeostasis and defence against infection. Gut 2019;68:400-13. [PMID: 29467166 DOI: 10.1136/gutjnl-2017-314540] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 92 |
Kakiuchi T, Matsuo M, Sakata Y, Fujimoto K, Granito A. Clinical Evaluation of a Novel Stool Antigen Test Using Bioluminescent Enzyme Immunoassay for Detecting Helicobacter pylori. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-8. [DOI: 10.1155/2022/5571542] [Reference Citation Analysis]
|
| 93 |
Valenzuela-Valderrama M, Cerda-Opazo P, Backert S, González MF, Carrasco-Véliz N, Jorquera-Cordero C, Wehinger S, Canales J, Bravo D, Quest AFG. The Helicobacter pylori Urease Virulence Factor Is Required for the Induction of Hypoxia-Induced Factor-1α in Gastric Cells. Cancers (Basel) 2019;11:E799. [PMID: 31185594 DOI: 10.3390/cancers11060799] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 94 |
Toyoshima O, Tanikawa C, Yamamoto R, Watanabe H, Yamashita H, Sakitani K, Yoshida S, Kubo M, Matsuo K, Ito H, Koike K, Seto Y, Matsuda K. Decrease in PSCA expression caused by Helicobacter pylori infection may promote progression to severe gastritis. Oncotarget. 2018;9:3936-3945. [PMID: 29423095 DOI: 10.18632/oncotarget.23278] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 95 |
Liang L, Fang JY, Xu J. Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy. Oncogene. 2016;35:1475-1482. [PMID: 26073079 DOI: 10.1038/onc.2015.209] [Cited by in Crossref: 60] [Cited by in F6Publishing: 67] [Article Influence: 8.6] [Reference Citation Analysis]
|
| 96 |
El-assaad F, Gong L, Gia A, Yim HCH, El-omar EM. Helicobacter pylori, Peptic Ulcer Disease and Gastric Cancer. Gastrointestinal Diseases and their Associated Infections. Elsevier; 2019. pp. 17-29. [DOI: 10.1016/b978-0-323-54843-4.00002-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 97 |
Diab M, Shemis M, Gamal D, El-shenawy A, El-ghannam M, El-sherbini E, Saber M. Helicobacter pylori Western cagA genotype in Egyptian patients with upper gastrointestinal disease. Egyptian Journal of Medical Human Genetics 2018;19:297-300. [DOI: 10.1016/j.ejmhg.2018.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 98 |
Kim HW, Woo HJ, Yang JY, Kim JB, Kim SH. Hesperetin Inhibits Expression of Virulence Factors and Growth of Helicobacter pylori. Int J Mol Sci 2021;22:10035. [PMID: 34576198 DOI: 10.3390/ijms221810035] [Reference Citation Analysis]
|
| 99 |
Cover TL, Lacy DB, Ohi MD. The Helicobacter pylori Cag Type IV Secretion System. Trends Microbiol 2020;28:682-95. [PMID: 32451226 DOI: 10.1016/j.tim.2020.02.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 100 |
Alipour M. Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer. J Gastrointest Cancer. 2021;52:23-30. [PMID: 32926335 DOI: 10.1007/s12029-020-00518-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 101 |
Bui Q, Grazziotin-soares D, Hasiniatsy RE, Trinh H, Richard S, Lotz J, Gligorov J, Khalil A. Cancer de l’estomac métastatique : les essais cliniques en Asie et en Occident. Bulletin du Cancer 2018;105:932-43. [DOI: 10.1016/j.bulcan.2018.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 102 |
Amieva M, Peek RM. Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterology. 2016;150:64-78. [PMID: 26385073 DOI: 10.1053/j.gastro.2015.09.004] [Cited by in Crossref: 335] [Cited by in F6Publishing: 302] [Article Influence: 47.9] [Reference Citation Analysis]
|
| 103 |
Shah MA. Update on metastatic gastric and esophageal cancers. J Clin Oncol. 2015;33:1760-1769. [PMID: 25918288 DOI: 10.1200/jco.2014.60.1799] [Cited by in Crossref: 104] [Cited by in F6Publishing: 66] [Article Influence: 14.9] [Reference Citation Analysis]
|
| 104 |
Costa TRD, Harb L, Khara P, Zeng L, Hu B, Christie PJ. Type IV secretion systems: Advances in structure, function, and activation. Mol Microbiol 2021;115:436-52. [PMID: 33326642 DOI: 10.1111/mmi.14670] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 105 |
Magnelli L, Schiavone N, Staderini F, Biagioni A, Papucci L. MAP Kinases Pathways in Gastric Cancer. Int J Mol Sci 2020;21:E2893. [PMID: 32326163 DOI: 10.3390/ijms21082893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 106 |
Cover TL. Helicobacter pylori diversity and gastric cancer risk. MBio. 2016;7:e01869-e01815. [PMID: 26814181 DOI: 10.1128/mbio.01869-15] [Cited by in Crossref: 99] [Cited by in F6Publishing: 65] [Article Influence: 16.5] [Reference Citation Analysis]
|
| 107 |
Takahashi-kanemitsu A, Knight CT, Hatakeyama M. Molecular anatomy and pathogenic actions of Helicobacter pylori CagA that underpin gastric carcinogenesis. Cell Mol Immunol 2020;17:50-63. [DOI: 10.1038/s41423-019-0339-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 108 |
Yahiro K, Hirayama T, Moss J, Noda M. New Insights into VacA Intoxication Mediated through Its Cell Surface Receptors. Toxins (Basel) 2016;8:E152. [PMID: 27187473 DOI: 10.3390/toxins8050152] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 109 |
Teng YS, Liu YG, Chen XH, Wang TT, Cheng P, Lv YP, Kong H, Mao FY, Hao CJ, Yang SM, Chen W, Zhang JY, Peng LS, Han B, Ma Q, Han J, Zou QM, Zhuang Y. Decreased IL-17RB expression impairs CD11b+CD11c- myeloid cell accumulation in gastric mucosa and host defense during the early-phase of Helicobacter pylori infection. Cell Death Dis 2019;10:79. [PMID: 30692510 DOI: 10.1038/s41419-019-1312-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 110 |
Kokate SB, Dixit P, Das L, Rath S, Roy AD, Poirah I, Chakraborty D, Rout N, Singh SP, Bhattacharyya A. Acetylation-mediated Siah2 stabilization enhances PHD3 degradation in Helicobacter pylori-infected gastric epithelial cancer cells. FASEB J 2018;32:5378-89. [PMID: 29688807 DOI: 10.1096/fj.201701344RRR] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 111 |
Kakiuchi T, Okuda M, Hashiguchi K, Imamura I, Nakayama A, Matsuo M. Evaluation of a Novel Stool Antigen Rapid Test Kit for Detection of Helicobacter pylori Infection. J Clin Microbiol 2019;57:e01825-18. [PMID: 30567746 DOI: 10.1128/JCM.01825-18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 112 |
Su H, Tissera K, Jang S, Choi YH, Kim A, Cho YJ, Li M, Gunawardhana N, Merrell DS, Ge L, Cha JH. Evolutionary mechanism leading to the multi-cagA genotype in Helicobacter pylori. Sci Rep 2019;9:11203. [PMID: 31371778 DOI: 10.1038/s41598-019-47240-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 113 |
Cover TL. Tracking bacterial effector protein delivery into host cells. Mol Microbiol 2021. [PMID: 34250669 DOI: 10.1111/mmi.14784] [Reference Citation Analysis]
|
| 114 |
Tepler A, Narula N, Peek RM Jr, Patel A, Edelson C, Colombel JF, Shah SC. Systematic review with meta-analysis: association between Helicobacter pylori CagA seropositivity and odds of inflammatory bowel disease. Aliment Pharmacol Ther 2019;50:121-31. [PMID: 31165513 DOI: 10.1111/apt.15306] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 115 |
Lima de Souza Gonçalves V, Cordeiro Santos ML, Silva Luz M, Santos Marques H, de Brito BB, França da Silva FA, Souza CL, Oliveira MV, de Melo FF. From Helicobacter pylori infection to gastric cancer: Current evidence on the immune response. World J Clin Oncol 2022; 13(3): 186-199 [DOI: 10.5306/wjco.v13.i3.186] [Reference Citation Analysis]
|
| 116 |
McClain MS, Beckett AC, Cover TL. Helicobacter pylori Vacuolating Toxin and Gastric Cancer. Toxins (Basel). 2017;9. [PMID: 29023421 DOI: 10.3390/toxins9100316] [Cited by in Crossref: 54] [Cited by in F6Publishing: 44] [Article Influence: 10.8] [Reference Citation Analysis]
|
| 117 |
Diechler S, Chichirau BE, Posselt G, Sgouras DN, Wessler S. Helicobacter pylori CagA EPIYA Motif Variations Affect Metabolic Activity in B Cells. Toxins (Basel) 2021;13:592. [PMID: 34564597 DOI: 10.3390/toxins13090592] [Reference Citation Analysis]
|
| 118 |
Ben C, Wu X, Takahashi-Kanemitsu A, Knight CT, Hayashi T, Hatakeyama M. Alternative splicing reverses the cell-intrinsic and cell-extrinsic pro-oncogenic potentials of YAP1. J Biol Chem 2020;295:13965-80. [PMID: 32763976 DOI: 10.1074/jbc.RA120.013820] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 119 |
Contreras M, Fernández-Delgado M, Reyes N, García-Amado MA, Rojas H, Michelangeli F. Helicobacter pylori Infection in Rural and Urban Dyspeptic Patients from Venezuela. Am J Trop Med Hyg 2015;93:730-2. [PMID: 26195456 DOI: 10.4269/ajtmh.15-0021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 120 |
Vitale G, Dicitore A, Barrea L, Sbardella E, Razzore P, Campione S, Faggiano A, Colao A, Albertelli M, Altieri B, Bottiglieri F, De Cicco F, Di Molfetta S, Fanciulli G, Feola T, Ferone D, Ferraù F, Gallo M, Giannetta E, Grillo F, Grossrubatscher E, Guadagno E, Guarnotta V, Isidori AM, Lania A, Lenzi A, Calzo FL, Malandrino P, Messina E, Modica R, Muscogiuri G, Pes L, Pizza G, Pofi R, Puliani G, Rainone C, Rizza L, Rubino M, Ruggieri RM, Sesti F, Venneri MA, Zatelli MC; NIKE. From microbiota toward gastro-enteropancreatic neuroendocrine neoplasms: Are we on the highway to hell? Rev Endocr Metab Disord 2021;22:511-25. [PMID: 32935263 DOI: 10.1007/s11154-020-09589-y] [Reference Citation Analysis]
|
| 121 |
Zhang C, Cleveland K, Schnoll-Sussman F, McClure B, Bigg M, Thakkar P, Schultz N, Shah MA, Betel D. Identification of low abundance microbiome in clinical samples using whole genome sequencing. Genome Biol. 2015;16:265. [PMID: 26614063 DOI: 10.1186/s13059-015-0821-z] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 122 |
Bernardini G, Figura N, Ponzetto A, Marzocchi B, Santucci A. Application of proteomics to the study of Helicobacter pylori and implications for the clinic. Expert Rev Proteomics 2017;14:477-90. [PMID: 28513226 DOI: 10.1080/14789450.2017.1331739] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 123 |
Farahani NN, Kalani BS, Monavari SH, Mirkalantari S, Montazer F, Sholeh M, Javanmard Z, Irajian G. Therapeutic effects, immunogenicity and cytotoxicity of a cell penetrating peptide-peptide nucleic acid conjugate against cagA of Helicobacter pylori in cell culture and animal model. Iran J Microbiol 2021;13:360-71. [PMID: 34540175 DOI: 10.18502/ijm.v13i3.6399] [Reference Citation Analysis]
|
| 124 |
Schlaermann P, Toelle B, Berger H, Schmidt SC, Glanemann M, Ordemann J, Bartfeld S, Mollenkopf HJ, Meyer TF. A novel human gastric primary cell culture system for modelling Helicobacter pylori infection in vitro. Gut 2016;65:202-13. [PMID: 25539675 DOI: 10.1136/gutjnl-2014-307949] [Cited by in Crossref: 126] [Cited by in F6Publishing: 127] [Article Influence: 15.8] [Reference Citation Analysis]
|
| 125 |
Li HJ, Fang EH, Wang JQ, Zheng LD, Tong QS. Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions. Curr Med Sci 2020;40:95-103. [PMID: 32166670 DOI: 10.1007/s11596-020-2151-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 126 |
Shimizu T, Marusawa H, Watanabe N, Chiba T. Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer. Gastroenterol Clin North Am. 2015;44:625-638. [PMID: 26314672 DOI: 10.1016/j.gtc.2015.05.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 127 |
Nishizawa T, Suzuki H. Gastric Carcinogenesis and Underlying Molecular Mechanisms: Helicobacter pylori and Novel Targeted Therapy. Biomed Res Int. 2015;2015:794378. [PMID: 25945346 DOI: 10.1155/2015/794378] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 128 |
Harrer A, Boehm M, Backert S, Tegtmeyer N. Overexpression of serine protease HtrA enhances disruption of adherens junctions, paracellular transmigration and type IV secretion of CagA by Helicobacter pylori. Gut Pathog 2017;9:40. [PMID: 28770008 DOI: 10.1186/s13099-017-0189-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 129 |
Ou Y, Ren H, Zhao R, Song L, Liu Z, Xu W, Liu Y, Wang S. Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway. Mol Carcinog 2019;58:1427-37. [PMID: 31162747 DOI: 10.1002/mc.23025] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 130 |
Buti L, Ruiz-Puig C, Sangberg D, Leissing TM, Brewer RC, Owen RP, Sgromo B, Royer C, Ebner D, Lu X. CagA-ASPP2 complex mediates loss of cell polarity and favors H. pylori colonization of human gastric organoids. Proc Natl Acad Sci U S A 2020;117:2645-55. [PMID: 31964836 DOI: 10.1073/pnas.1908787117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 131 |
Yang E, Chua W, Ng W, Roberts TL. Peripheral Cytokine Levels as a Prognostic Indicator in Gastric Cancer: A Review of Existing Literature. Biomedicines 2021;9:1916. [PMID: 34944729 DOI: 10.3390/biomedicines9121916] [Reference Citation Analysis]
|
| 132 |
Thieblemont C, Zucca E. Clinical aspects and therapy of gastrointestinal MALT lymphoma. Best Pract Res Clin Haematol. 2017;30:109-117. [PMID: 28288705 DOI: 10.1016/j.beha.2017.01.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 133 |
Posselt G, Wiesauer M, Chichirau BE, Engler D, Krisch LM, Gadermaier G, Briza P, Schneider S, Boccellato F, Meyer TF, Hauser-Kronberger C, Neureiter D, Müller A, Wessler S. Helicobacter pylori-controlled c-Abl localization promotes cell migration and limits apoptosis. Cell Commun Signal 2019;17:10. [PMID: 30704478 DOI: 10.1186/s12964-019-0323-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 134 |
Tsilimigras MC, Fodor A, Jobin C. Carcinogenesis and therapeutics: The microbiota perspective. Nat Microbiol. 2017;2:17008. [PMID: 28225000 DOI: 10.1038/nmicrobiol.2017.8] [Cited by in Crossref: 62] [Cited by in F6Publishing: 51] [Article Influence: 12.4] [Reference Citation Analysis]
|
| 135 |
Liu X, Meltzer SJ. Gastric Cancer in the Era of Precision Medicine. Cell Mol Gastroenterol Hepatol 2017;3:348-58. [PMID: 28462377 DOI: 10.1016/j.jcmgh.2017.02.003] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 11.4] [Reference Citation Analysis]
|
| 136 |
Watanabe T, Asano N, Kudo M, Strober W. Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:578-599. [PMID: 29021509 DOI: 10.2183/pjab.93.037] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 137 |
Bergé C, Terradot L. Structural Insights into Helicobacter pylori Cag Protein Interactions with Host Cell Factors. Curr Top Microbiol Immunol 2017;400:129-47. [PMID: 28124152 DOI: 10.1007/978-3-319-50520-6_6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 138 |
Ailloud F, Didelot X, Woltemate S, Pfaffinger G, Overmann J, Bader RC, Schulz C, Malfertheiner P, Suerbaum S. Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps. Nat Commun. 2019;10:2273. [PMID: 31118420 DOI: 10.1038/s41467-019-10050-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 139 |
Li B, Li YM, Guo JW, Wei YC. Relationship between Helicobacter pylori infection and gastric cancer. Shijie Huaren Xiaohua Zazhi 2015; 23(7): 1083-1089 [DOI: 10.11569/wcjd.v23.i7.1083] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 140 |
Fukayama M, Abe H, Kunita A, Shinozaki-Ushiku A, Matsusaka K, Ushiku T, Kaneda A. Thirty years of Epstein-Barr virus-associated gastric carcinoma. Virchows Arch 2020;476:353-65. [PMID: 31836926 DOI: 10.1007/s00428-019-02724-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 141 |
Rosadi F, Fiorentini C, Fabbri A, Frisan T. Bacterial protein toxins in human cancers. Pathogens and Disease 2015;74:ftv105. [DOI: 10.1093/femspd/ftv105] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 142 |
Morozov V, Borkowski J, Hanisch FG. The Double Face of Mucin-Type O-Glycans in Lectin-Mediated Infection and Immunity. Molecules 2018;23:E1151. [PMID: 29751628 DOI: 10.3390/molecules23051151] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 143 |
Wessler S, Krisch LM, Elmer DP, Aberger F. From inflammation to gastric cancer - the importance of Hedgehog/GLI signaling in Helicobacter pylori-induced chronic inflammatory and neoplastic diseases. Cell Commun Signal 2017;15:15. [PMID: 28427431 DOI: 10.1186/s12964-017-0171-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 144 |
Teufel A, Quante M, Kandulski A, Hirth M, Zhan T, Eckardt M, Thieme R, Kusnik A, Yesmembetov K, Wiest I, Riemann JF, Schlitt HJ, Gockel I, Malfertheiner P, Ebert MP. [Prevention of gastrointestinal cancer]. Z Gastroenterol 2021;59:964-82. [PMID: 34507375 DOI: 10.1055/a-1540-7539] [Reference Citation Analysis]
|
| 145 |
Mladenova I. Clinical Relevance of Helicobacter pylori Infection. J Clin Med 2021;10:3473. [PMID: 34441769 DOI: 10.3390/jcm10163473] [Reference Citation Analysis]
|
| 146 |
Yu J, Zhao Y, Wang X, Xu Y. Evaluation of Anti-Helicobacter pylori IgG Antibodies for the Detection of Helicobacter pylori Infection in Different Populations. Diagnostics 2022;12:1214. [DOI: 10.3390/diagnostics12051214] [Reference Citation Analysis]
|
| 147 |
Eom SY, Hong SM, Yim DH, Kwon HJ, Kim DH, Yun HY, Song YJ, Youn SJ, Hyun T, Park JS, Kim BS, Kim YD, Kim H. Additive interactions between PRKAA1 polymorphisms and Helicobacter pylori CagA infection associated with gastric cancer risk in Koreans. Cancer Med 2016;5:3236-335. [PMID: 27726301 DOI: 10.1002/cam4.926] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 148 |
Eyvazi S, Vostakolaei MA, Dilmaghani A, Borumandi O, Hejazi MS, Kahroba H, Tarhriz V. The oncogenic roles of bacterial infections in development of cancer. Microb Pathog 2020;141:104019. [PMID: 32006638 DOI: 10.1016/j.micpath.2020.104019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 149 |
Scanu T, Spaapen RM, Bakker JM, Pratap CB, Wu LE, Hofland I, Broeks A, Shukla VK, Kumar M, Janssen H. Salmonella Manipulation of Host Signaling Pathways Provokes Cellular Transformation Associated with Gallbladder Carcinoma. Cell Host Microbe. 2015;17:763-774. [PMID: 26028364 DOI: 10.1016/j.chom.2015.05.002] [Cited by in Crossref: 113] [Cited by in F6Publishing: 103] [Article Influence: 16.1] [Reference Citation Analysis]
|
| 150 |
Wang G, Romero-Gallo J, Benoit SL, Piazuelo MB, Dominguez RL, Morgan DR, Peek RM Jr, Maier RJ. Hydrogen Metabolism in Helicobacter pylori Plays a Role in Gastric Carcinogenesis through Facilitating CagA Translocation. mBio 2016;7:e01022-16. [PMID: 27531909 DOI: 10.1128/mBio.01022-16] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 151 |
Liu Z, Wu X, Tian Y, Zhang W, Qiao S, Xu W, Liu Y, Wang S. H. pylori infection induces CXCL8 expression and promotes gastric cancer progress through downregulating KLF4. Mol Carcinog 2021;60:524-37. [PMID: 34038586 DOI: 10.1002/mc.23309] [Reference Citation Analysis]
|
| 152 |
Kokate SB, Dixit P, Poirah I, Roy AD, Chakraborty D, Rout N, Singh SP, Ashktorab H, Smoot DT, Bhattacharyya A. Testin and filamin-C downregulation by acetylated Siah2 increases invasiveness of Helicobacter pylori-infected gastric cancer cells. Int J Biochem Cell Biol 2018;103:14-24. [PMID: 30063986 DOI: 10.1016/j.biocel.2018.07.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 153 |
Kamogawa-Schifter Y, Yamaoka Y, Uchida T, Beer A, Tribl B, Schöniger-Hekele M, Trauner M, Dolak W. Prevalence of Helicobacter pylori and its CagA subtypes in gastric cancer and duodenal ulcer at an Austrian tertiary referral center over 25 years. PLoS One 2018;13:e0197695. [PMID: 29813089 DOI: 10.1371/journal.pone.0197695] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 154 |
Molina-Castro SE, Tiffon C, Giraud J, Boeuf H, Sifre E, Giese A, Belleannée G, Lehours P, Bessède E, Mégraud F, Dubus P, Staedel C, Varon C. The Hippo Kinase LATS2 Controls Helicobacter pylori-Induced Epithelial-Mesenchymal Transition and Intestinal Metaplasia in Gastric Mucosa. Cell Mol Gastroenterol Hepatol 2020;9:257-76. [PMID: 31669263 DOI: 10.1016/j.jcmgh.2019.10.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 155 |
Posselt G, Crabtree JE, Wessler S. Proteolysis in Helicobacter pylori-Induced Gastric Cancer. Toxins (Basel) 2017;9:E134. [PMID: 28398251 DOI: 10.3390/toxins9040134] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 156 |
Mohammadi A, Khanbabaei H, Zandi F, Ahmadi A, Haftcheshmeh SM, Johnston TP, Sahebkar A. Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases. Microbial Pathogenesis 2022. [DOI: 10.1016/j.micpath.2022.105552] [Reference Citation Analysis]
|
| 157 |
Lin AS, McClain MS, Beckett AC, Caston RR, Harvey ML, Dixon BREA, Campbell AM, Shuman JHB, Sawhney N, Delgado AG, Loh JT, Piazuelo MB, Algood HMS, Cover TL. Temporal Control of the Helicobacter pylori Cag Type IV Secretion System in a Mongolian Gerbil Model of Gastric Carcinogenesis. mBio 2020;11:e01296-20. [PMID: 32605987 DOI: 10.1128/mBio.01296-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 158 |
Bullock KK, Shaffer CL, Brooks AW, Secka O, Forsyth MH, McClain MS, Cover TL. Genetic signatures for Helicobacter pylori strains of West African origin. PLoS One 2017;12:e0188804. [PMID: 29186206 DOI: 10.1371/journal.pone.0188804] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 159 |
Ternes D, Karta J, Tsenkova M, Wilmes P, Haan S, Letellier E. Microbiome in Colorectal Cancer: How to Get from Meta-omics to Mechanism? Trends Microbiol. 2020;28:401-423. [PMID: 32298617 DOI: 10.1016/j.tim.2020.01.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 160 |
Hansen JP, Ali WM, Sivadasan R, Rajeeve K. Bacteria-Cancer Interface: Awaiting the Perfect Storm. Pathogens 2021;10:1321. [PMID: 34684270 DOI: 10.3390/pathogens10101321] [Reference Citation Analysis]
|
| 161 |
Peng C, Ouyang Y, Lu N, Li N. The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances. Front Immunol 2020;11:1387. [PMID: 32695120 DOI: 10.3389/fimmu.2020.01387] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 162 |
Ishimoto T, Miyake K, Nandi T, Yashiro M, Onishi N, Huang KK, Lin SJ, Kalpana R, Tay ST, Suzuki Y, Cho BC, Kuroda D, Arima K, Izumi D, Iwatsuki M, Baba Y, Oki E, Watanabe M, Saya H, Hirakawa K, Baba H, Tan P. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells. Gastroenterology 2017;153:191-204.e16. [PMID: 28390866 DOI: 10.1053/j.gastro.2017.03.046] [Cited by in Crossref: 71] [Cited by in F6Publishing: 80] [Article Influence: 14.2] [Reference Citation Analysis]
|
| 163 |
Li N, Xie C, Lu NH. Transforming growth factor-β: an important mediator in Helicobacter pylori-associated pathogenesis. Front Cell Infect Microbiol. 2015;5:77. [PMID: 26583078 DOI: 10.3389/fcimb.2015.00077] [Cited by in Crossref: 9] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 164 |
Mishra JP, Cohen D, Zamperone A, Nesic D, Muesch A, Stein M. CagA of Helicobacter pylori interacts with and inhibits the serine-threonine kinase PRK2. Cell Microbiol 2015;17:1670-82. [PMID: 26041307 DOI: 10.1111/cmi.12464] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 165 |
Shimoda A, Ueda K, Nishiumi S, Murata-Kamiya N, Mukai SA, Sawada S, Azuma T, Hatakeyama M, Akiyoshi K. Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA. Sci Rep. 2016;6:18346. [PMID: 26739388 DOI: 10.1038/srep18346] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 166 |
Ruch TR, Engel JN. Targeting the Mucosal Barrier: How Pathogens Modulate the Cellular Polarity Network. Cold Spring Harb Perspect Biol 2017;9:a027953. [PMID: 28193722 DOI: 10.1101/cshperspect.a027953] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 167 |
Mi Y, Dong H, Sun X, Ren F, Tang Y, Zheng P. The association of Helicobacter pylori CagA EPIYA motifs and vacA genotypes with homologous recombination repair markers during the gastric precancerous cascade. Int J Biol Markers 2020;35:49-55. [PMID: 32286927 DOI: 10.1177/1724600820914935] [Reference Citation Analysis]
|
| 168 |
Sripa B, Tangkawattana S, Brindley PJ. Update on Pathogenesis of Opisthorchiasis and Cholangiocarcinoma. Asiatic Liver Fluke - From Basic Science to Public Health, Part B. Elsevier; 2018. pp. 97-113. [DOI: 10.1016/bs.apar.2018.10.001] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 169 |
Fujiwara-Tani R, Okamoto A, Katsuragawa H, Ohmori H, Fujii K, Mori S, Kishi S, Sasaki T, Nakashima C, Kawahara I, Hojo Y, Nishiguchi Y, Mori T, Mizumoto T, Nagai K, Luo Y, Kuniyasu H. BRAF Mutation Is Associated with Hyperplastic Polyp-Associated Gastric Cancer. Int J Mol Sci 2021;22:12724. [PMID: 34884530 DOI: 10.3390/ijms222312724] [Reference Citation Analysis]
|
| 170 |
Peng C, Li N, Hu Y, Lu N. Impact factors that modulate gastric cancer risk in Helicobacter pylori ‐infected rodent models. Helicobacter 2019. [DOI: 10.1111/hel.12580] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 171 |
Vital JS, Tanoeiro L, Lopes-oliveira R, Vale FF. Biomarker Characterization and Prediction of Virulence and Antibiotic Resistance from Helicobacter pylori Next Generation Sequencing Data. Biomolecules 2022;12:691. [DOI: 10.3390/biom12050691] [Reference Citation Analysis]
|
| 172 |
Nishizuka SS, Tamura G, Nakatochi M, Fukushima N, Ohmori Y, Sumida C, Iwaya T, Takahashi T, Koeda K; Northern Japan Gastric Cancer Study Consortium. Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy. J Surg Oncol 2018;117:947-56. [PMID: 29355977 DOI: 10.1002/jso.24977] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 173 |
Ji J, Yang H. Using Probiotics as Supplementation for Helicobacter pylori Antibiotic Therapy.Int J Mol Sci. 2020;21. [PMID: 32046317 DOI: 10.3390/ijms21031136] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 174 |
Krishnan V, Lim DXE, Hoang PM, Srivastava S, Matsuo J, Huang KK, Zhu F, Ho KY, So JBY, Khor C, Tsao S, Teh M, Fock KM, Ang TL, Jeyasekharan AD, Tan P, Yeoh KG, Ito Y. DNA damage signalling as an anti-cancer barrier in gastric intestinal metaplasia. Gut 2020;69:1738-49. [PMID: 31937549 DOI: 10.1136/gutjnl-2019-319002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 175 |
Ponzetto A, Figura N. High hepatocellular carcinoma risk among US-born Hispanics. Cancer 2017;123:357. [PMID: 27741362 DOI: 10.1002/cncr.30397] [Reference Citation Analysis]
|
| 176 |
Kakiuchi T, Hashiguchi K, Imamura I, Nakayama A, Takamori A, Okuda M, Matsuo M. Assessment of a novel method to detect clarithromycin-resistant Helicobacter pylori using a stool antigen test reagent. BMC Gastroenterol 2020;20:397. [PMID: 33228552 DOI: 10.1186/s12876-020-01549-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 177 |
Senda Y, Hatakeyama M. CagA. In: Suzuki H, Warren R, Marshall B, editors. Helicobacter pylori. Tokyo: Springer Japan; 2016. pp. 33-47. [DOI: 10.1007/978-4-431-55705-0_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 178 |
Yamada S, Okamura T, Kobayashi S, Tanaka E, Nakayama J. Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach. J Gastroenterol Hepatol 2015;30:1478-84. [PMID: 25967588 DOI: 10.1111/jgh.13000] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 179 |
Minaga K, Watanabe T, Kamata K, Asano N, Kudo M. Nucleotide-binding oligomerization domain 1 and Helicobacter pylori infection: A review. World J Gastroenterol 2018; 24(16): 1725-1733 [PMID: 29713127 DOI: 10.3748/wjg.v24.i16.1725] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 180 |
Waldum H, Fossmark R. Gastritis, Gastric Polyps and Gastric Cancer. Int J Mol Sci 2021;22:6548. [PMID: 34207192 DOI: 10.3390/ijms22126548] [Reference Citation Analysis]
|
| 181 |
Lettl C, Haas R, Fischer W. Kinetics of CagA type IV secretion by Helicobacter pylori and the requirement for substrate unfolding. Mol Microbiol 2021. [PMID: 34121254 DOI: 10.1111/mmi.14772] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 182 |
Fujii Y, Murata-Kamiya N, Hatakeyama M. Helicobacter pylori CagA oncoprotein interacts with SHIP2 to increase its delivery into gastric epithelial cells. Cancer Sci 2020;111:1596-606. [PMID: 32198795 DOI: 10.1111/cas.14391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 183 |
Chen J, Pitmon E, Wang K. Microbiome, inflammation and colorectal cancer. Semin Immunol. 2017;32:43-53. [PMID: 28982615 DOI: 10.1016/j.smim.2017.09.006] [Cited by in Crossref: 102] [Cited by in F6Publishing: 101] [Article Influence: 20.4] [Reference Citation Analysis]
|
| 184 |
Zhao R, Liu Z, Xu W, Song L, Ren H, Ou Y, Liu Y, Wang S. Helicobacter pylori infection leads to KLF4 inactivation in gastric cancer through a TET1-mediated DNA methylation mechanism. Cancer Med 2020;9:2551-63. [PMID: 32017451 DOI: 10.1002/cam4.2892] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 185 |
Soutto M, Chen Z, Katsha AM, Romero-Gallo J, Krishna US, Piazuelo MB, Washington MK, Peek RM Jr, Belkhiri A, El-Rifai WM. Trefoil factor 1 expression suppresses Helicobacter pylori-induced inflammation in gastric carcinogenesis. Cancer 2015;121:4348-58. [PMID: 26372254 DOI: 10.1002/cncr.29644] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 186 |
Peña J, Rojas H, Reyes N, Fernández-Delgado M, García-Amado MA, Michelangeli F, Contreras M. Multiple cag genotypes of Helicobacter pylori isolates colonize the oesophagus in individual hosts in a Venezuelan population. J Med Microbiol 2017;66:226-35. [PMID: 27983473 DOI: 10.1099/jmm.0.000409] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 187 |
Senga SS, Grose RP. Hallmarks of cancer-the new testament. Open Biol 2021;11:200358. [PMID: 33465324 DOI: 10.1098/rsob.200358] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 188 |
Chang CC, Kuo WS, Chen YC, Perng CL, Lin HJ, Ou YH. Fragmentation of CagA Reduces Hummingbird Phenotype Induction by Helicobactor pylori. PLoS One 2016;11:e0150061. [PMID: 26934189 DOI: 10.1371/journal.pone.0150061] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 189 |
Yadegar A, Mohabati Mobarez A, Zali MR. Genetic diversity and amino acid sequence polymorphism in Helicobacter pylori CagL hypervariable motif and its association with virulence markers and gastroduodenal diseases. Cancer Med 2019;8:1619-32. [PMID: 30873747 DOI: 10.1002/cam4.1941] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 190 |
Zhang C, Powell SE, Betel D, Shah MA. The gastric microbiome and its influence on gastric carcinogenesis: current knowledge and ongoing research. Hematol Oncol Clin North Am. 2017;31:389-408. [PMID: 28501083 DOI: 10.1016/j.hoc.2017.01.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 191 |
Holleczek B, Schöttker B, Brenner H. Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population‐based ESTHER cohort study. Int J Cancer 2020;146:2773-83. [DOI: 10.1002/ijc.32610] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 192 |
Alon-Maimon T, Mandelboim O, Bachrach G. Fusobacterium nucleatum and cancer. Periodontol 2000 2022. [PMID: 35244982 DOI: 10.1111/prd.12426] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 193 |
Lin AS, Dooyema SDR, Frick-Cheng AE, Harvey ML, Suarez G, Loh JT, McDonald WH, McClain MS, Peek RM Jr, Cover TL. Bacterial Energetic Requirements for Helicobacter pylori Cag Type IV Secretion System-Dependent Alterations in Gastric Epithelial Cells. Infect Immun 2020;88:e00790-19. [PMID: 31712269 DOI: 10.1128/IAI.00790-19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 194 |
Zhang XS, Tegtmeyer N, Traube L, Jindal S, Perez-Perez G, Sticht H, Backert S, Blaser MJ. A specific A/T polymorphism in Western tyrosine phosphorylation B-motifs regulates Helicobacter pylori CagA epithelial cell interactions. PLoS Pathog. 2015;11:e1004621. [PMID: 25646814 DOI: 10.1371/journal.ppat.1004621] [Cited by in Crossref: 66] [Cited by in F6Publishing: 61] [Article Influence: 9.4] [Reference Citation Analysis]
|
| 195 |
Xu T, Xie M, Jing X, Cui J, Wu X, Shu Y. Crosstalk between Environmental Inflammatory Stimuli and Non-Coding RNA in Cancer Occurrence and Development. Cancers (Basel) 2021;13:4436. [PMID: 34503246 DOI: 10.3390/cancers13174436] [Reference Citation Analysis]
|
| 196 |
Sáenz JB, Mills JC. Helicobacter pylori: preying on SIVA for survival in the stomach. J Clin Invest 2020;130:2183-5. [PMID: 32250343 DOI: 10.1172/JCI135508] [Reference Citation Analysis]
|
| 197 |
Bartpho TS, Wattanawongdon W, Tongtawee T, Paoin C, Kangwantas K, Dechsukhum C. Precancerous Gastric Lesions with Helicobacter pylori vacA +/babA2+/oipA + Genotype Increase the Risk of Gastric Cancer. Biomed Res Int 2020;2020:7243029. [PMID: 32149129 DOI: 10.1155/2020/7243029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 198 |
Niu Q, Zhu J, Yu X, Feng T, Ji H, Li Y, Zhang W, Hu B. Immune Response in H. pylori-Associated Gastritis and Gastric Cancer. Gastroenterol Res Pract. 2020;2020:9342563. [PMID: 32411209 DOI: 10.1155/2020/9342563] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 199 |
Voss BJ, Loh JT, Hill S, Rose KL, McDonald WH, Cover TL. Alteration of the Helicobacter pylori membrane proteome in response to changes in environmental salt concentration. Proteomics Clin Appl 2015;9:1021-34. [PMID: 26109032 DOI: 10.1002/prca.201400176] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 200 |
Koelblen T, Bergé C, Cherrier MV, Brillet K, Jimenez-soto L, Ballut L, Takagi J, Montserret R, Rousselle P, Fischer W, Haas R, Fronzes R, Terradot L. Molecular dissection of protein-protein interactions between integrin α5β1 and the Helicobacter pylori Cag type IV secretion system. FEBS J 2017;284:4143-57. [DOI: 10.1111/febs.14299] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 201 |
Shin MK, Jun JS, Kwon SW, Lee DH, Ha JH, Park JS, Kang HL, Baik SC, Park JS, Seo JH, Youn HS, Cho MJ, Lee WK. Characterizing antigenic determinants in Helicobacter pylori CagA capable of detecting serum antibodies in children. Pathog Dis 2017;75. [PMID: 28934419 DOI: 10.1093/femspd/ftx103] [Reference Citation Analysis]
|
| 202 |
Sukri A, Hanafiah A, Kosai NR, Mohamed Taher M, Mohamed Rose I. Surface Antigen Profiling of Helicobacter pylori -Infected and -Uninfected Gastric Cancer Cells Using Antibody Microarray. Helicobacter 2016;21:417-27. [DOI: 10.1111/hel.12295] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 203 |
Sripa B, Deenonpoe R, Brindley PJ. Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma? Parasitol Int 2017;66:383-9. [PMID: 27919744 DOI: 10.1016/j.parint.2016.11.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 204 |
Ferreira RM, Pinto-Ribeiro I, Wen X, Marcos-Pinto R, Dinis-Ribeiro M, Carneiro F, Figueiredo C. Helicobacter pylori cagA Promoter Region Sequences Influence CagA Expression and Interleukin 8 Secretion. J Infect Dis. 2016;213:669-673. [PMID: 26401027 DOI: 10.1093/infdis/jiv467] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 205 |
Wu MC, Cheng HH, Yeh TS, Li YC, Chen TJ, Sit WY, Chuu CP, Kung HJ, Chien S, Wang WC. KDM4B is a coactivator of c-Jun and involved in gastric carcinogenesis. Cell Death Dis 2019;10:68. [PMID: 30683841 DOI: 10.1038/s41419-019-1305-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 206 |
Mao LQ, Zhou YL, Wang SS, Chen L, Hu Y, Yu LM, Xu JM, Lyu B. Impact of Helicobacter pylori eradication on the gastric microbiome. Gut Pathog 2021;13:60. [PMID: 34645495 DOI: 10.1186/s13099-021-00460-2] [Reference Citation Analysis]
|
| 207 |
Tsugawa H, Kato C, Mori H, Matsuzaki J, Kameyama K, Saya H, Hatakeyama M, Suematsu M, Suzuki H. Cancer Stem-Cell Marker CD44v9-Positive Cells Arise From Helicobacter pylori-Infected CAPZA1-Overexpressing Cells. Cell Mol Gastroenterol Hepatol 2019;8:319-34. [PMID: 31146068 DOI: 10.1016/j.jcmgh.2019.05.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 208 |
Martins DJ, Matos GC, Loiola RS, D'Annibale V, Corvelo T. Relationship of vitamin D receptor gene polymorphisms in Helicobacter pylori gastric patients. Clin Exp Gastroenterol 2018;11:19-27. [PMID: 29391820 DOI: 10.2147/CEG.S143332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 209 |
Xue Z, You Y, He L, Gong Y, Sun L, Han X, Fan R, Zhai K, Yang Y, Zhang M, Yan X, Zhang J. Diversity of 3' variable region of cagA gene in Helicobacter pylori strains isolated from Chinese population. Gut Pathog 2021;13:23. [PMID: 33849660 DOI: 10.1186/s13099-021-00419-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 210 |
Palrasu M, Zaika E, El-Rifai W, Garcia-Buitrago M, Piazuelo MB, Wilson KT, Peek RM Jr, Zaika AI. Bacterial CagA protein compromises tumor suppressor mechanisms in gastric epithelial cells. J Clin Invest 2020;130:2422-34. [PMID: 32250340 DOI: 10.1172/JCI130015] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
|
| 211 |
Park CH, Lee AR, Lee YR, Eun CS, Lee SK, Han DS. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing. Helicobacter 2019;24:e12547. [PMID: 30440093 DOI: 10.1111/hel.12547] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 212 |
Polakovicova I, Jerez S, Wichmann IA, Sandoval-Bórquez A, Carrasco-Véliz N, Corvalán AH. Role of microRNAs and Exosomes in Helicobacter pylori and Epstein-Barr Virus Associated Gastric Cancers. Front Microbiol 2018;9:636. [PMID: 29675003 DOI: 10.3389/fmicb.2018.00636] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 213 |
Deenonpoe R, Mairiang E, Mairiang P, Pairojkul C, Chamgramol Y, Rinaldi G, Loukas A, Brindley PJ, Sripa B. Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease. Sci Rep 2017;7:42744. [PMID: 28198451 DOI: 10.1038/srep42744] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 214 |
Kaakoush NO, Castaño-Rodríguez N, Man SM, Mitchell HM. Is Campylobacter to esophageal adenocarcinoma as Helicobacter is to gastric adenocarcinoma? Trends Microbiol 2015;23:455-62. [PMID: 25937501 DOI: 10.1016/j.tim.2015.03.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 215 |
Frick-Cheng AE, Pyburn TM, Voss BJ, McDonald WH, Ohi MD, Cover TL. Molecular and Structural Analysis of the Helicobacter pylori cag Type IV Secretion System Core Complex. mBio 2016;7:e02001-15. [PMID: 26758182 DOI: 10.1128/mBio.02001-15] [Cited by in Crossref: 74] [Cited by in F6Publishing: 48] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 216 |
Yoon JH, Choi BJ, Nam SW, Park WS. Gastric cancer exosomes contribute to the field cancerization of gastric epithelial cells surrounding gastric cancer. Gastric Cancer 2022. [PMID: 34993738 DOI: 10.1007/s10120-021-01269-3] [Reference Citation Analysis]
|
| 217 |
Ponzetto A, Figura N, Holton J. Comment on 'Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung'. Br J Cancer 2017;116:e5. [PMID: 27764845 DOI: 10.1038/bjc.2016.338] [Reference Citation Analysis]
|
| 218 |
Brennan CA, Garrett WS. Fusobacterium nucleatum - symbiont, opportunist and oncobacterium. Nat Rev Microbiol. 2019;17:156-166. [PMID: 30546113 DOI: 10.1038/s41579-018-0129-6] [Cited by in Crossref: 193] [Cited by in F6Publishing: 179] [Article Influence: 96.5] [Reference Citation Analysis]
|
| 219 |
Iino C, Shimoyama T. Impact of Helicobacter pylori infection on gut microbiota. World J Gastroenterol 2021; 27(37): 6224-6230 [PMID: 34712028 DOI: 10.3748/wjg.v27.i37.6224] [Reference Citation Analysis]
|
| 220 |
Sáenz JB, Mills JC. Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer. Nat Rev Gastroenterol Hepatol 2018;15:257-73. [PMID: 29463907 DOI: 10.1038/nrgastro.2018.5] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 221 |
Schindele F, Weiss E, Haas R, Fischer W. Quantitative analysis of CagA type IV secretion by Helicobacterpylori reveals substrate recognition and translocation requirements: Quantification of CagA type IV secretion. Molecular Microbiology 2016;100:188-203. [DOI: 10.1111/mmi.13309] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 222 |
Thanaphongdecha P, Karinshak SE, Ittiprasert W, Mann VH, Chamgramol Y, Pairojkul C, Fox JG, Suttiprapa S, Sripa B, Brindley PJ. Infection with Helicobacter pylori Induces Epithelial to Mesenchymal Transition in Human Cholangiocytes. Pathogens 2020;9:E971. [PMID: 33233485 DOI: 10.3390/pathogens9110971] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 223 |
Hatakeyama M. Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:196-219. [PMID: 28413197 DOI: 10.2183/pjab.93.013] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 224 |
Warsinggih, Syarifuddin E, Marhamah, Lusikooy RE, Labeda I, Sampetoding S, Dani MI, Kusuma MI, Uwuratuw JA, Prihantono, Faruk M. Association of clinicopathological features and gastric cancer incidence in a single institution. Asian J Surg 2021:S1015-9584(21)00261-X. [PMID: 34090784 DOI: 10.1016/j.asjsur.2021.05.004] [Reference Citation Analysis]
|
| 225 |
Zhu GH, Sang YT, Li J. Role and significance of traditional Chinese medicine in regulating gastrointestinal microecology to prevent and treat gastrointestinal cancer. Shijie Huaren Xiaohua Zazhi 2020; 28(1): 1-8 [DOI: 10.11569/wcjd.v28.i1.1] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 226 |
Brüggemann H, Al-Zeer MA. Bacterial signatures and their inflammatory potentials associated with prostate cancer. APMIS 2020;128:80-91. [PMID: 31990107 DOI: 10.1111/apm.13021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 227 |
Mori H, Suzuki H, Matsuzaki J, Kameyama K, Igarashi K, Masaoka T, Kanai T. Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication. Annals of Medicine 2022;54:170-80. [DOI: 10.1080/07853890.2021.2024875] [Reference Citation Analysis]
|
| 228 |
Chmiela M, Karwowska Z, Gonciarz W, Allushi B, Stączek P. Host pathogen interactions in Helicobacter pylori related gastric cancer. World J Gastroenterol 2017; 23(9): 1521-1540 [PMID: 28321154 DOI: 10.3748/wjg.v23.i9.1521] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 229 |
Jangam D, Butzmann A, Sridhar K, Deresinski S, Banaei N, Shigeo Ohgami R. Significance of bacterial and viral genotypes as a risk factor in driving cancer (Review). Mol Clin Oncol 2020;13:3-12. [PMID: 32499911 DOI: 10.3892/mco.2020.2043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 230 |
Suzuki N, Murata-Kamiya N, Yanagiya K, Suda W, Hattori M, Kanda H, Bingo A, Fujii Y, Maeda S, Koike K. Mutual reinforcement of inflammation and carcinogenesis by the Helicobacter pylori CagA oncoprotein. Sci Rep. 2015;5:10024. [PMID: 25944120 DOI: 10.1038/srep10024] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 231 |
Kuang WM, Ren YJ, Chen X, Luo Q, Chen W, Pan HG, Li RL, Hu L. Association between serum vitamin D levels and Helicobacter pylori cytotoxic-associated gene A seropositivity: a cross-sectional study in US adults from NHANES III. BMJ Open 2022;12:e058164. [PMID: 35418433 DOI: 10.1136/bmjopen-2021-058164] [Reference Citation Analysis]
|
| 232 |
Dai B, Xiang A, Qu D, Chen G, Wang L, Wang W, Zhai D, Wang L, Lu Z. Rapid and Sensitive Assay of Helicobacter pylori With One-Tube RPA-CRISPR/Cas12 by Portable Array Detector for Visible Analysis of Thermostatic Nucleic Acid Amplification. Front Microbiol 2022;13:858247. [DOI: 10.3389/fmicb.2022.858247] [Reference Citation Analysis]
|
| 233 |
Donati C, Zolfo M, Albanese D, Tin Truong D, Asnicar F, Iebba V, Cavalieri D, Jousson O, De Filippo C, Huttenhower C, Segata N. Uncovering oral Neisseria tropism and persistence using metagenomic sequencing. Nat Microbiol 2016;1:16070. [PMID: 27572971 DOI: 10.1038/nmicrobiol.2016.70] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
|
| 234 |
Nair MR, Chouhan D, Sen Gupta S, Chattopadhyay S. Fermented Foods: Are They Tasty Medicines for Helicobacter pylori Associated Peptic Ulcer and Gastric Cancer? Front Microbiol 2016;7:1148. [PMID: 27504109 DOI: 10.3389/fmicb.2016.01148] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 235 |
Wang F, Song M, Lu X, Zhu X, Deng J. Gut microbes in gastrointestinal cancers. Semin Cancer Biol 2021:S1044-579X(21)00098-5. [PMID: 33812983 DOI: 10.1016/j.semcancer.2021.03.037] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 236 |
Sougleri IS, Papadakos KS, Zadik MP, Mavri-Vavagianni M, Mentis AF, Sgouras DN. Helicobacter pylori CagA protein induces factors involved in the epithelial to mesenchymal transition (EMT) in infected gastric epithelial cells in an EPIYA- phosphorylation-dependent manner. FEBS J. 2016;283:206-220. [PMID: 26907789 DOI: 10.1111/febs.13592] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 237 |
Zhang L, Xiao Y, Ji L, Lin M, Zou Y, Zhao J, Zhao S. Potential Therapeutic Effects of Egg Yolk Antibody (IgY) in Helicobacter pylori Infections─A Review. J Agric Food Chem 2021;69:13691-9. [PMID: 34783242 DOI: 10.1021/acs.jafc.1c05398] [Reference Citation Analysis]
|
| 238 |
Hu Y, He C, Liu J, Li N, Peng C, Yang‐ou Y, Yang X, Lu N, Zhu Y. Analysis of key genes and signaling pathways involved in Helicobacter pylori ‐associated gastric cancer based on The Cancer Genome Atlas database and RNA sequencing data. Helicobacter 2018;23:e12530. [DOI: 10.1111/hel.12530] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 239 |
Gur C, Maalouf N, Gerhard M, Singer BB, Emgård J, Temper V, Neuman T, Mandelboim O, Bachrach G. The Helicobacter pylori HopQ outermembrane protein inhibits immune cell activities. Oncoimmunology 2019;8:e1553487. [PMID: 30906650 DOI: 10.1080/2162402X.2018.1553487] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 240 |
FitzGerald R, Sinha C, Yadegar A, Smith SM. Helicobacter pylori Virulence Factor Genotyping. Methods Mol Biol 2021;2283:93-106. [PMID: 33765313 DOI: 10.1007/978-1-0716-1302-3_11] [Reference Citation Analysis]
|
| 241 |
Jafar M, Salahuddin M, Khan MSA, Alshehry Y, Alrwaili NR, Alzahrani YA, Imam SS, Alshehri S. Preparation and In Vitro-In Vivo Evaluation of Luteolin Loaded Gastroretentive Microsponge for the Eradication of Helicobacter pylori Infections. Pharmaceutics 2021;13:2094. [PMID: 34959375 DOI: 10.3390/pharmaceutics13122094] [Reference Citation Analysis]
|
| 242 |
O'Rourke F, Mändle T, Urbich C, Dimmeler S, Michaelis UR, Brandes RP, Flötenmeyer M, Döring C, Hansmann ML, Lauber K, Ballhorn W, Kempf VA. Reprogramming of myeloid angiogenic cells by Bartonella henselae leads to microenvironmental regulation of pathological angiogenesis. Cell Microbiol 2015;17:1447-63. [PMID: 25857345 DOI: 10.1111/cmi.12447] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 243 |
Menheniott TR, Judd LM, Giraud AS. STAT3: a critical component in the response to Helicobacter pylori infection. Cell Microbiol 2015;17:1570-82. [PMID: 26332850 DOI: 10.1111/cmi.12518] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 244 |
Merino E, Flores-Encarnación M, Aguilar-Gutiérrez GR. Functional interaction and structural characteristics of unique components of Helicobacter pylori T4SS. FEBS J 2017;284:3540-9. [PMID: 28470874 DOI: 10.1111/febs.14092] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 245 |
Afzali S, Mandegary A, Alimolaei M, Heidari M. Seroprevalence of Anti-Helicobacter pylori and Anti-CagA IgG Antibodies in Iranian Dyspeptic Patients. Int J Enteric Pathog 2018;6:56-9. [DOI: 10.15171/ijep.2018.16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 246 |
Toyoshima O, Nishizawa T, Koike K. Endoscopic Kyoto classification of Helicobacter pylori infection and gastric cancer risk diagnosis. World J Gastroenterol 2020; 26(5): 466-477 [PMID: 32089624 DOI: 10.3748/wjg.v26.i5.466] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
|
